Differentiation of Common Myeloid Progenitor Cells
Target Cell Response to Hormones
Regulation of Hematopoietic Stem Cells
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 6, 2026

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
Published on: January 27, 2023
Joseph G Cannon1, Barbara Kraj, Gloria Sloan
1School of Allied Health Sciences, Medical College of Georgia, Augusta, GA 30912, USA. jcannon@mcg.edu
Elevated follicle-stimulating hormone (FSH) may increase bone loss by promoting osteoclast precursor cells. This study found FSH significantly increased a key osteoclast marker on myeloid cells, suggesting a novel mechanism for bone density decline.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: